0
  • Category
  • Region
U.S. (TOLL FREE)
+1 (315) 215-3225
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Infectious Disease Research Solutions Market Research Report 2025
Published Date: February 2025
|
Report Code: QYRE-Auto-2A19117
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Infectious Disease Research Solutions Market Research Report 2025
BUY CHAPTERS

Global Infectious Disease Research Solutions Market Research Report 2025

Code: QYRE-Auto-2A19117
Report
February 2025
Pages:85
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Infectious Disease Research Solutions Market Size

The global market for Infectious Disease Research Solutions was valued at US$ 2655 million in the year 2024 and is projected to reach a revised size of US$ 3939 million by 2031, growing at a CAGR of 5.9% during the forecast period.

Infectious Disease Research Solutions Market

Infectious Disease Research Solutions Market

Infectious Disease Research Solutions refer to the range of tools, technologies, methodologies, and services designed to support the study, detection, treatment, and prevention of infectious diseases. These solutions are developed and employed by researchers, healthcare professionals, and pharmaceutical companies to better understand pathogens (bacteria, viruses, fungi, etc.), how they spread, and how to combat them effectively.
North American market for Infectious Disease Research Solutions is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Infectious Disease Research Solutions is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Infectious Disease Research Solutions in Viral Infection is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Infectious Disease Research Solutions include Thermo Fisher Scientific, Revvity, Sino Biological, Roche, Agilent, IQVIA, Boca Bio, Sartorius, Charles River, Microbix Biosystems, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Infectious Disease Research Solutions, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Infectious Disease Research Solutions.
The Infectious Disease Research Solutions market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Infectious Disease Research Solutions market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Infectious Disease Research Solutions companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Infectious Disease Research Solutions Market Report

Report Metric Details
Report Name Infectious Disease Research Solutions Market
Accounted market size in year US$ 2655 million
Forecasted market size in 2031 US$ 3939 million
CAGR 5.9%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Molecular Diagnostics
  • Vaccine Development
  • Therapeutic Options
  • Drug Discovery and Screening
  • Epidemiology Tools and Data Analysis
Segment by Application
  • Viral Infection
  • Bacterial Infection
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Thermo Fisher Scientific, Revvity, Sino Biological, Roche, Agilent, IQVIA, Boca Bio, Sartorius, Charles River, Microbix Biosystems, Quidel Ortho, Bio-Rad Laboratories, Abbott Laboratories
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Infectious Disease Research Solutions company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Infectious Disease Research Solutions Market growing?

Ans: The Infectious Disease Research Solutions Market witnessing a CAGR of 5.9% during the forecast period 2025-2031.

What is the Infectious Disease Research Solutions Market size in 2031?

Ans: The Infectious Disease Research Solutions Market size in 2031 will be US$ 3939 million.

Who are the main players in the Infectious Disease Research Solutions Market report?

Ans: The main players in the Infectious Disease Research Solutions Market are Thermo Fisher Scientific, Revvity, Sino Biological, Roche, Agilent, IQVIA, Boca Bio, Sartorius, Charles River, Microbix Biosystems, Quidel Ortho, Bio-Rad Laboratories, Abbott Laboratories

What are the Application segmentation covered in the Infectious Disease Research Solutions Market report?

Ans: The Applications covered in the Infectious Disease Research Solutions Market report are Viral Infection, Bacterial Infection

What are the Type segmentation covered in the Infectious Disease Research Solutions Market report?

Ans: The Types covered in the Infectious Disease Research Solutions Market report are Molecular Diagnostics, Vaccine Development, Therapeutic Options, Drug Discovery and Screening, Epidemiology Tools and Data Analysis

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Infectious Disease Research Solutions Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Molecular Diagnostics
1.2.3 Vaccine Development
1.2.4 Therapeutic Options
1.2.5 Drug Discovery and Screening
1.2.6 Epidemiology Tools and Data Analysis
1.3 Market by Application
1.3.1 Global Infectious Disease Research Solutions Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Viral Infection
1.3.3 Bacterial Infection
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Infectious Disease Research Solutions Market Perspective (2020-2031)
2.2 Global Infectious Disease Research Solutions Growth Trends by Region
2.2.1 Global Infectious Disease Research Solutions Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Infectious Disease Research Solutions Historic Market Size by Region (2020-2025)
2.2.3 Infectious Disease Research Solutions Forecasted Market Size by Region (2026-2031)
2.3 Infectious Disease Research Solutions Market Dynamics
2.3.1 Infectious Disease Research Solutions Industry Trends
2.3.2 Infectious Disease Research Solutions Market Drivers
2.3.3 Infectious Disease Research Solutions Market Challenges
2.3.4 Infectious Disease Research Solutions Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Infectious Disease Research Solutions Players by Revenue
3.1.1 Global Top Infectious Disease Research Solutions Players by Revenue (2020-2025)
3.1.2 Global Infectious Disease Research Solutions Revenue Market Share by Players (2020-2025)
3.2 Global Top Infectious Disease Research Solutions Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Infectious Disease Research Solutions Revenue
3.4 Global Infectious Disease Research Solutions Market Concentration Ratio
3.4.1 Global Infectious Disease Research Solutions Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Infectious Disease Research Solutions Revenue in 2024
3.5 Global Key Players of Infectious Disease Research Solutions Head office and Area Served
3.6 Global Key Players of Infectious Disease Research Solutions, Product and Application
3.7 Global Key Players of Infectious Disease Research Solutions, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Infectious Disease Research Solutions Breakdown Data by Type
4.1 Global Infectious Disease Research Solutions Historic Market Size by Type (2020-2025)
4.2 Global Infectious Disease Research Solutions Forecasted Market Size by Type (2026-2031)
5 Infectious Disease Research Solutions Breakdown Data by Application
5.1 Global Infectious Disease Research Solutions Historic Market Size by Application (2020-2025)
5.2 Global Infectious Disease Research Solutions Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Infectious Disease Research Solutions Market Size (2020-2031)
6.2 North America Infectious Disease Research Solutions Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Infectious Disease Research Solutions Market Size by Country (2020-2025)
6.4 North America Infectious Disease Research Solutions Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Infectious Disease Research Solutions Market Size (2020-2031)
7.2 Europe Infectious Disease Research Solutions Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Infectious Disease Research Solutions Market Size by Country (2020-2025)
7.4 Europe Infectious Disease Research Solutions Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Infectious Disease Research Solutions Market Size (2020-2031)
8.2 Asia-Pacific Infectious Disease Research Solutions Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Infectious Disease Research Solutions Market Size by Region (2020-2025)
8.4 Asia-Pacific Infectious Disease Research Solutions Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Infectious Disease Research Solutions Market Size (2020-2031)
9.2 Latin America Infectious Disease Research Solutions Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Infectious Disease Research Solutions Market Size by Country (2020-2025)
9.4 Latin America Infectious Disease Research Solutions Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Infectious Disease Research Solutions Market Size (2020-2031)
10.2 Middle East & Africa Infectious Disease Research Solutions Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Infectious Disease Research Solutions Market Size by Country (2020-2025)
10.4 Middle East & Africa Infectious Disease Research Solutions Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Infectious Disease Research Solutions Introduction
11.1.4 Thermo Fisher Scientific Revenue in Infectious Disease Research Solutions Business (2020-2025)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Revvity
11.2.1 Revvity Company Details
11.2.2 Revvity Business Overview
11.2.3 Revvity Infectious Disease Research Solutions Introduction
11.2.4 Revvity Revenue in Infectious Disease Research Solutions Business (2020-2025)
11.2.5 Revvity Recent Development
11.3 Sino Biological
11.3.1 Sino Biological Company Details
11.3.2 Sino Biological Business Overview
11.3.3 Sino Biological Infectious Disease Research Solutions Introduction
11.3.4 Sino Biological Revenue in Infectious Disease Research Solutions Business (2020-2025)
11.3.5 Sino Biological Recent Development
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche Infectious Disease Research Solutions Introduction
11.4.4 Roche Revenue in Infectious Disease Research Solutions Business (2020-2025)
11.4.5 Roche Recent Development
11.5 Agilent
11.5.1 Agilent Company Details
11.5.2 Agilent Business Overview
11.5.3 Agilent Infectious Disease Research Solutions Introduction
11.5.4 Agilent Revenue in Infectious Disease Research Solutions Business (2020-2025)
11.5.5 Agilent Recent Development
11.6 IQVIA
11.6.1 IQVIA Company Details
11.6.2 IQVIA Business Overview
11.6.3 IQVIA Infectious Disease Research Solutions Introduction
11.6.4 IQVIA Revenue in Infectious Disease Research Solutions Business (2020-2025)
11.6.5 IQVIA Recent Development
11.7 Boca Bio
11.7.1 Boca Bio Company Details
11.7.2 Boca Bio Business Overview
11.7.3 Boca Bio Infectious Disease Research Solutions Introduction
11.7.4 Boca Bio Revenue in Infectious Disease Research Solutions Business (2020-2025)
11.7.5 Boca Bio Recent Development
11.8 Sartorius
11.8.1 Sartorius Company Details
11.8.2 Sartorius Business Overview
11.8.3 Sartorius Infectious Disease Research Solutions Introduction
11.8.4 Sartorius Revenue in Infectious Disease Research Solutions Business (2020-2025)
11.8.5 Sartorius Recent Development
11.9 Charles River
11.9.1 Charles River Company Details
11.9.2 Charles River Business Overview
11.9.3 Charles River Infectious Disease Research Solutions Introduction
11.9.4 Charles River Revenue in Infectious Disease Research Solutions Business (2020-2025)
11.9.5 Charles River Recent Development
11.10 Microbix Biosystems
11.10.1 Microbix Biosystems Company Details
11.10.2 Microbix Biosystems Business Overview
11.10.3 Microbix Biosystems Infectious Disease Research Solutions Introduction
11.10.4 Microbix Biosystems Revenue in Infectious Disease Research Solutions Business (2020-2025)
11.10.5 Microbix Biosystems Recent Development
11.11 Quidel Ortho
11.11.1 Quidel Ortho Company Details
11.11.2 Quidel Ortho Business Overview
11.11.3 Quidel Ortho Infectious Disease Research Solutions Introduction
11.11.4 Quidel Ortho Revenue in Infectious Disease Research Solutions Business (2020-2025)
11.11.5 Quidel Ortho Recent Development
11.12 Bio-Rad Laboratories
11.12.1 Bio-Rad Laboratories Company Details
11.12.2 Bio-Rad Laboratories Business Overview
11.12.3 Bio-Rad Laboratories Infectious Disease Research Solutions Introduction
11.12.4 Bio-Rad Laboratories Revenue in Infectious Disease Research Solutions Business (2020-2025)
11.12.5 Bio-Rad Laboratories Recent Development
11.13 Abbott Laboratories
11.13.1 Abbott Laboratories Company Details
11.13.2 Abbott Laboratories Business Overview
11.13.3 Abbott Laboratories Infectious Disease Research Solutions Introduction
11.13.4 Abbott Laboratories Revenue in Infectious Disease Research Solutions Business (2020-2025)
11.13.5 Abbott Laboratories Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Infectious Disease Research Solutions Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Molecular Diagnostics
 Table 3. Key Players of Vaccine Development
 Table 4. Key Players of Therapeutic Options
 Table 5. Key Players of Drug Discovery and Screening
 Table 6. Key Players of Epidemiology Tools and Data Analysis
 Table 7. Global Infectious Disease Research Solutions Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Infectious Disease Research Solutions Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Global Infectious Disease Research Solutions Market Size by Region (2020-2025) & (US$ Million)
 Table 10. Global Infectious Disease Research Solutions Market Share by Region (2020-2025)
 Table 11. Global Infectious Disease Research Solutions Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 12. Global Infectious Disease Research Solutions Market Share by Region (2026-2031)
 Table 13. Infectious Disease Research Solutions Market Trends
 Table 14. Infectious Disease Research Solutions Market Drivers
 Table 15. Infectious Disease Research Solutions Market Challenges
 Table 16. Infectious Disease Research Solutions Market Restraints
 Table 17. Global Infectious Disease Research Solutions Revenue by Players (2020-2025) & (US$ Million)
 Table 18. Global Infectious Disease Research Solutions Market Share by Players (2020-2025)
 Table 19. Global Top Infectious Disease Research Solutions Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease Research Solutions as of 2024)
 Table 20. Ranking of Global Top Infectious Disease Research Solutions Companies by Revenue (US$ Million) in 2024
 Table 21. Global 5 Largest Players Market Share by Infectious Disease Research Solutions Revenue (CR5 and HHI) & (2020-2025)
 Table 22. Global Key Players of Infectious Disease Research Solutions, Headquarters and Area Served
 Table 23. Global Key Players of Infectious Disease Research Solutions, Product and Application
 Table 24. Global Key Players of Infectious Disease Research Solutions, Date of Enter into This Industry
 Table 25. Mergers & Acquisitions, Expansion Plans
 Table 26. Global Infectious Disease Research Solutions Market Size by Type (2020-2025) & (US$ Million)
 Table 27. Global Infectious Disease Research Solutions Revenue Market Share by Type (2020-2025)
 Table 28. Global Infectious Disease Research Solutions Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 29. Global Infectious Disease Research Solutions Revenue Market Share by Type (2026-2031)
 Table 30. Global Infectious Disease Research Solutions Market Size by Application (2020-2025) & (US$ Million)
 Table 31. Global Infectious Disease Research Solutions Revenue Market Share by Application (2020-2025)
 Table 32. Global Infectious Disease Research Solutions Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 33. Global Infectious Disease Research Solutions Revenue Market Share by Application (2026-2031)
 Table 34. North America Infectious Disease Research Solutions Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. North America Infectious Disease Research Solutions Market Size by Country (2020-2025) & (US$ Million)
 Table 36. North America Infectious Disease Research Solutions Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Europe Infectious Disease Research Solutions Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Europe Infectious Disease Research Solutions Market Size by Country (2020-2025) & (US$ Million)
 Table 39. Europe Infectious Disease Research Solutions Market Size by Country (2026-2031) & (US$ Million)
 Table 40. Asia-Pacific Infectious Disease Research Solutions Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Asia-Pacific Infectious Disease Research Solutions Market Size by Region (2020-2025) & (US$ Million)
 Table 42. Asia-Pacific Infectious Disease Research Solutions Market Size by Region (2026-2031) & (US$ Million)
 Table 43. Latin America Infectious Disease Research Solutions Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Latin America Infectious Disease Research Solutions Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Latin America Infectious Disease Research Solutions Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Middle East & Africa Infectious Disease Research Solutions Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 47. Middle East & Africa Infectious Disease Research Solutions Market Size by Country (2020-2025) & (US$ Million)
 Table 48. Middle East & Africa Infectious Disease Research Solutions Market Size by Country (2026-2031) & (US$ Million)
 Table 49. Thermo Fisher Scientific Company Details
 Table 50. Thermo Fisher Scientific Business Overview
 Table 51. Thermo Fisher Scientific Infectious Disease Research Solutions Product
 Table 52. Thermo Fisher Scientific Revenue in Infectious Disease Research Solutions Business (2020-2025) & (US$ Million)
 Table 53. Thermo Fisher Scientific Recent Development
 Table 54. Revvity Company Details
 Table 55. Revvity Business Overview
 Table 56. Revvity Infectious Disease Research Solutions Product
 Table 57. Revvity Revenue in Infectious Disease Research Solutions Business (2020-2025) & (US$ Million)
 Table 58. Revvity Recent Development
 Table 59. Sino Biological Company Details
 Table 60. Sino Biological Business Overview
 Table 61. Sino Biological Infectious Disease Research Solutions Product
 Table 62. Sino Biological Revenue in Infectious Disease Research Solutions Business (2020-2025) & (US$ Million)
 Table 63. Sino Biological Recent Development
 Table 64. Roche Company Details
 Table 65. Roche Business Overview
 Table 66. Roche Infectious Disease Research Solutions Product
 Table 67. Roche Revenue in Infectious Disease Research Solutions Business (2020-2025) & (US$ Million)
 Table 68. Roche Recent Development
 Table 69. Agilent Company Details
 Table 70. Agilent Business Overview
 Table 71. Agilent Infectious Disease Research Solutions Product
 Table 72. Agilent Revenue in Infectious Disease Research Solutions Business (2020-2025) & (US$ Million)
 Table 73. Agilent Recent Development
 Table 74. IQVIA Company Details
 Table 75. IQVIA Business Overview
 Table 76. IQVIA Infectious Disease Research Solutions Product
 Table 77. IQVIA Revenue in Infectious Disease Research Solutions Business (2020-2025) & (US$ Million)
 Table 78. IQVIA Recent Development
 Table 79. Boca Bio Company Details
 Table 80. Boca Bio Business Overview
 Table 81. Boca Bio Infectious Disease Research Solutions Product
 Table 82. Boca Bio Revenue in Infectious Disease Research Solutions Business (2020-2025) & (US$ Million)
 Table 83. Boca Bio Recent Development
 Table 84. Sartorius Company Details
 Table 85. Sartorius Business Overview
 Table 86. Sartorius Infectious Disease Research Solutions Product
 Table 87. Sartorius Revenue in Infectious Disease Research Solutions Business (2020-2025) & (US$ Million)
 Table 88. Sartorius Recent Development
 Table 89. Charles River Company Details
 Table 90. Charles River Business Overview
 Table 91. Charles River Infectious Disease Research Solutions Product
 Table 92. Charles River Revenue in Infectious Disease Research Solutions Business (2020-2025) & (US$ Million)
 Table 93. Charles River Recent Development
 Table 94. Microbix Biosystems Company Details
 Table 95. Microbix Biosystems Business Overview
 Table 96. Microbix Biosystems Infectious Disease Research Solutions Product
 Table 97. Microbix Biosystems Revenue in Infectious Disease Research Solutions Business (2020-2025) & (US$ Million)
 Table 98. Microbix Biosystems Recent Development
 Table 99. Quidel Ortho Company Details
 Table 100. Quidel Ortho Business Overview
 Table 101. Quidel Ortho Infectious Disease Research Solutions Product
 Table 102. Quidel Ortho Revenue in Infectious Disease Research Solutions Business (2020-2025) & (US$ Million)
 Table 103. Quidel Ortho Recent Development
 Table 104. Bio-Rad Laboratories Company Details
 Table 105. Bio-Rad Laboratories Business Overview
 Table 106. Bio-Rad Laboratories Infectious Disease Research Solutions Product
 Table 107. Bio-Rad Laboratories Revenue in Infectious Disease Research Solutions Business (2020-2025) & (US$ Million)
 Table 108. Bio-Rad Laboratories Recent Development
 Table 109. Abbott Laboratories Company Details
 Table 110. Abbott Laboratories Business Overview
 Table 111. Abbott Laboratories Infectious Disease Research Solutions Product
 Table 112. Abbott Laboratories Revenue in Infectious Disease Research Solutions Business (2020-2025) & (US$ Million)
 Table 113. Abbott Laboratories Recent Development
 Table 114. Research Programs/Design for This Report
 Table 115. Key Data Information from Secondary Sources
 Table 116. Key Data Information from Primary Sources
 Table 117. Authors List of This Report


List of Figures
 Figure 1. Infectious Disease Research Solutions Picture
 Figure 2. Global Infectious Disease Research Solutions Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Infectious Disease Research Solutions Market Share by Type: 2024 VS 2031
 Figure 4. Molecular Diagnostics Features
 Figure 5. Vaccine Development Features
 Figure 6. Therapeutic Options Features
 Figure 7. Drug Discovery and Screening Features
 Figure 8. Epidemiology Tools and Data Analysis Features
 Figure 9. Global Infectious Disease Research Solutions Market Size by Application (2020-2031) & (US$ Million)
 Figure 10. Global Infectious Disease Research Solutions Market Share by Application: 2024 VS 2031
 Figure 11. Viral Infection Case Studies
 Figure 12. Bacterial Infection Case Studies
 Figure 13. Infectious Disease Research Solutions Report Years Considered
 Figure 14. Global Infectious Disease Research Solutions Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global Infectious Disease Research Solutions Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Infectious Disease Research Solutions Market Share by Region: 2024 VS 2031
 Figure 17. Global Infectious Disease Research Solutions Market Share by Players in 2024
 Figure 18. Global Infectious Disease Research Solutions Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 19. The Top 10 and 5 Players Market Share by Infectious Disease Research Solutions Revenue in 2024
 Figure 20. North America Infectious Disease Research Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America Infectious Disease Research Solutions Market Share by Country (2020-2031)
 Figure 22. United States Infectious Disease Research Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Infectious Disease Research Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Infectious Disease Research Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Infectious Disease Research Solutions Market Share by Country (2020-2031)
 Figure 26. Germany Infectious Disease Research Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Infectious Disease Research Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Infectious Disease Research Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Infectious Disease Research Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Infectious Disease Research Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Infectious Disease Research Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Infectious Disease Research Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Infectious Disease Research Solutions Market Share by Region (2020-2031)
 Figure 34. China Infectious Disease Research Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan Infectious Disease Research Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea Infectious Disease Research Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia Infectious Disease Research Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India Infectious Disease Research Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia Infectious Disease Research Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Infectious Disease Research Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Infectious Disease Research Solutions Market Share by Country (2020-2031)
 Figure 42. Mexico Infectious Disease Research Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil Infectious Disease Research Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Infectious Disease Research Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Infectious Disease Research Solutions Market Share by Country (2020-2031)
 Figure 46. Turkey Infectious Disease Research Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia Infectious Disease Research Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE Infectious Disease Research Solutions Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Thermo Fisher Scientific Revenue Growth Rate in Infectious Disease Research Solutions Business (2020-2025)
 Figure 50. Revvity Revenue Growth Rate in Infectious Disease Research Solutions Business (2020-2025)
 Figure 51. Sino Biological Revenue Growth Rate in Infectious Disease Research Solutions Business (2020-2025)
 Figure 52. Roche Revenue Growth Rate in Infectious Disease Research Solutions Business (2020-2025)
 Figure 53. Agilent Revenue Growth Rate in Infectious Disease Research Solutions Business (2020-2025)
 Figure 54. IQVIA Revenue Growth Rate in Infectious Disease Research Solutions Business (2020-2025)
 Figure 55. Boca Bio Revenue Growth Rate in Infectious Disease Research Solutions Business (2020-2025)
 Figure 56. Sartorius Revenue Growth Rate in Infectious Disease Research Solutions Business (2020-2025)
 Figure 57. Charles River Revenue Growth Rate in Infectious Disease Research Solutions Business (2020-2025)
 Figure 58. Microbix Biosystems Revenue Growth Rate in Infectious Disease Research Solutions Business (2020-2025)
 Figure 59. Quidel Ortho Revenue Growth Rate in Infectious Disease Research Solutions Business (2020-2025)
 Figure 60. Bio-Rad Laboratories Revenue Growth Rate in Infectious Disease Research Solutions Business (2020-2025)
 Figure 61. Abbott Laboratories Revenue Growth Rate in Infectious Disease Research Solutions Business (2020-2025)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

SIMILAR REPORTS